House Bill 7535 - Prescription Drug Supply Chain Pricing Transparency Act

Purpose and Summary

Chamber: House

Introduced date: 2024-03-05

Recent Activity

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Alternative Names

Prescription Drug Supply Chain Pricing Transparency Act

To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.

Prescription Drug Supply Chain Pricing Transparency Act

Associated Legislation

Modernizing and Ensuring PBM Accountability Act

Prescription Drug Supply Chain Pricing Transparency Act

Policy Areas

Health

Potential Impact

Sponsors and Supporters

Rep. Caraveo, Yadira [D-CO-8]

Cosponsors and Supporters

Rep. Mann, Tracey [R-KS-1]

Committees and Subcommittees

Ways and Means Committee

Energy and Commerce Committee

Variations and Revisions

Prescription Drug Supply Chain Pricing Transparency Act

3/27/2024, 10:30 PM
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the ...
Congress
118
Number
HR - 7535
Introduced on
2024-03-05
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

3/5/2024
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the ...
Alternative Names
Official Title as IntroducedTo require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
Policy Areas
Health

Comments

Recent Activity

Latest Action3/5/2024
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the ...